Login / Signup

Reduction in Nonabstinent WHO Drinking Risk Levels and Change in Risk for Liver Disease and Positive AUDIT-C Scores: Prospective 3-Year Follow-Up Results in the U.S. General Population.

Justin KnoxMelanie WallKatie A WitkiewitzHenry R KranzlerDaniel E FalkRaye LittenKarl F MannStephanie S O'MalleyJennifer ScodesRaymond K AntonDeborah S Hasinnull null
Published in: Alcoholism, clinical and experimental research (2018)
In the highest-risk drinkers, reductions in WHO drinking risk levels predicted lower likelihood of liver disease and positive AUDIT-C scores. Results add to findings that reductions in the 4-category WHO drinking risk levels are a meaningful indicator of how individuals feel and function, and could serve as nonabstinent end points in clinical trials. Results also connect the WHO risk drinking levels to commonly used alcohol screening questions, which may be more familiar to healthcare providers.
Keyphrases
  • healthcare
  • alcohol consumption
  • randomized controlled trial
  • social media